The prevalence and topographic distribution of penile calcification in a large cohort: a retrospective cross-sectional study.

Journal

International journal of impotence research

ISSN: 1476-5489

Titre abrégé: Int J Impot Res

Pays: England

ID NLM: 9007383

Informations de publication

Date de publication:
02 Sep 2023

Historique:

received: 04 03 2023

accepted: 18 08 2023

medline: 3 9 2023

pubmed: 3 9 2023

entrez: 2 9 2023

Statut: aheadofprint

Résumé

The prevalence of penile calcification in the population remains uncertain. This retrospective multicenter study aimed to determine the prevalence and characteristics of penile calcification in a large cohort of male patients undergoing non-contrast pelvic tomography. A total of 14 545 scans obtained from 19 participating centers between 2016 and 2022 were retrospectively analyzed within a 3-months period. Eligible scans (n = 12 709) were included in the analysis. Patient age, penile imaging status, presence of calcified plaque, and plaque measurements were recorded. Statistical analysis was performed to assess the relationships between calcified plaque, patient age, plaque characteristics, and plaque location. Among the analyzed scans, 767 (6.04%) patients were found to have at least one calcified plaque. Patients with calcified plaque had a significantly higher median age (64 years (IQR 56-72)) compared to those with normal penile evaluation (49 years (IQR 36-60) (p < 0.001). Of the patients with calcified plaque, 46.4% had only one plaque, while 53.6% had multiple plaques. There was a positive correlation between age and the number of plaques (r = 0.31, p < 0.001). The average dimensions of the calcified plaques were as follows: width: 3.9 ± 5 mm, length: 5.3 ± 5.2 mm, height: 3.5 ± 3.2 mm, with an average plaque area of 29 ± 165 mm² and mean plaque volume of 269 ± 3187 mm³. Plaques were predominantly located in the proximal and mid-penile regions (44.1% and 40.5%, respectively), with 77.7% located on the dorsal side of the penis. The hardness level of plaques, assessed by Hounsfield units, median of 362 (IQR 250-487) (range: 100-1400). Patients with multiple plaques had significantly higher Hounsfield unit values compared to those with a single plaque (p = 0.003). Our study revealed that patients with calcified plaques are older and have multiple plaques predominantly located on the dorsal and proximal side of the penis.

Identifiants

DOI: 10.1038/s41443-023-00758-6 PMID: 37660216

pubmed: 37660216

doi: 10.1038/s41443-023-00758-6

pii: 10.1038/s41443-023-00758-6

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Informations de copyright

Références

Devine CJ, Somers KD, Jordan SG, Schlossberg SM. Proposal: trauma as the cause of the Peyronie’s lesion. J Urol. 1997;157:285–90.

doi: 10.1016/S0022-5347(01)65361-8 pubmed: 8976281

Chung E, Ralph D, Kadioglu A, Garaffa G, Shamsodini A, Bivalacqua T, et al. Evidence-based management guidelines on Peyronie’s disease. J Sex Med. 2016;13:905–23.

doi: 10.1016/j.jsxm.2016.04.062 pubmed: 27215686

Di Maida F, Cito G, Lambertini L, Valastro F, Morelli G, Mari A, et al. The natural history of Peyronie’s disease. World J Mens Health. 2021;39:399–405.

doi: 10.5534/wjmh.200065 pubmed: 32648381

Garaffa G, Trost LW, Serefoglu EC, Ralph D, Hellstrom WJG. Understanding the course of Peyronie’s disease. Int J Clin Pract. 2013;67:781–8.

doi: 10.1111/ijcp.12129 pubmed: 23869679

Sommer F, Schwarzer U, Wassmer G, Bloch W, Braun M, Klotz T, et al. Epidemiology of Peyronie’s disease. Int J Impot Res. 2002;14:379–83.

doi: 10.1038/sj.ijir.3900863 pubmed: 12454689

Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie’s disease: results of a large survey. BJU Int. 2001;88:727–30.

doi: 10.1046/j.1464-4096.2001.02436.x pubmed: 11890244

Arafa M, Eid H, El-Badry A, Ezz-Eldine K, Shamloul R. The prevalence of Peyronie’s disease in diabetic patients with erectile dysfunction. Int J Impot Res. 2007;19:213–7.

doi: 10.1038/sj.ijir.3901518 pubmed: 16915304

Kadioglu A, Dincer M, Salabas E, Culha MG, Akdere H, Cilesiz NC. A population-based study of Peyronie’s disease in Turkey: prevalence and related comorbidities. Sex Med. 2020;8:679–85.

doi: 10.1016/j.esxm.2020.09.002 pubmed: 33243422 pmcid: 7691981

Goldstein I, McLane MP, Xiang Q, Wolfe HR, Hu Y, Gelbard MK. Long-term curvature deformity characterization in men previously treated with Collagenase Clostridium Histolyticum for Peyronie’s disease, subgrouped by penile plaque calcification. Urology. 2020;146:145–51.

doi: 10.1016/j.urology.2020.08.045 pubmed: 32896582

Levine L, Rybak J, Corder C, Farrel MR. Peyronie’s disease plaque calcification–prevalence, time to identification, and development of a new grading classification. J Sex Med. 2013;10:3121–8.

doi: 10.1111/jsm.12334 pubmed: 24119147

Wymer K, Ziegelmann M, Savage J, Kohler T, Trost L. Plaque calcification: an important predictor of collagenase clostridium histolyticum treatment outcomes for men with Peyronie’s disease. Urology 2018;119:109–14.

doi: 10.1016/j.urology.2018.06.003 pubmed: 29908867

Patel DP, Christensen MB, Hotaling JM, Pastuszak AW. A review of inflammation and fibrosis: implications for the pathogenesis of Peyronie’s disease. World J Urol. 2020;38:253–61.

doi: 10.1007/s00345-019-02815-6 pubmed: 31190155

Vernet D, Nolazco G, Cantini L, Magee TR, Qian A, Rajfer J, et al. Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: implications for peyronie disease. Biol Reprod. 2005;73:1199–210.

doi: 10.1095/biolreprod.105.041038 pubmed: 16093362

Gonzalez-Cadavid NF, Magee TR, Ferrini M, Qian A, Vernet D, Rajfer J. Gene expression in Peyronie’s disease. Int J Impot Res. 2002;14:361–74.

doi: 10.1038/sj.ijir.3900873 pubmed: 12454687

Rainer QC, Rodriguez AA, Bajic P, Galor A, Ramasamy R, Masterson TA. Implications of calcification in Peyronie’s disease, a review of the literature. Urology. 2021;152:52–9.

doi: 10.1016/j.urology.2021.01.007 pubmed: 33476600

Vande Berg JS, Devine CJ, Horton CE, Somers KD, Wright GL, Leffell MS, et al. Mechanisms of calcification in Peyronie’s disease. J Urol 1982;127:52–4.

doi: 10.1016/S0022-5347(17)53599-5 pubmed: 7057504

Bekos A, Arvaniti M, Hatzimouratidis K, Moysidis K, Tzortzis V, Hatzichristou D. The natural history of Peyronie’s disease: an ultrasonography-based study. Eur Urol. 2008;53:644–50.

doi: 10.1016/j.eururo.2007.07.013 pubmed: 17673362

Parmar M, Masterson JM, Masterson TA. The role of imaging in the diagnosis and management of Peyronie’s disease. Curr Opin Urol. 2020;30:283–9.

doi: 10.1097/MOU.0000000000000754 pubmed: 32205808

Gündoğdu E, Emekli E. Calcified Peyronie’s disease frequency on computed tomography. Turk J Urol. 2022;48:196–200.

doi: 10.5152/tud.2022.21346 pubmed: 35634937 pmcid: 9730267

Pawłowska E, Bianek-Bodzak A. Imaging modalities and clinical assesment in men affected with Peyronie’s disease. Pol J Radiol. 2011;76:33–7.

pubmed: 22802839 pmcid: 3389927

Andresen R, Wegner HE, Miller K, Banzer D. Imaging modalities in Peyronie’s disease. An intrapersonal comparison of ultrasound sonography, X-ray in mammography technique, computerized tomography, and nuclear magnetic resonance in 20 patients. Eur Urol 1998;34:128–34.

doi: 10.1159/000019698 pubmed: 9693248

Hounsfield GN. Computed medical imaging. Nobel lecture, Decemberr 8, 1979. J Comput Assist Tomogr. 1980;4:665–74.

doi: 10.1097/00004728-198010000-00017 pubmed: 6997341

Glide-Hurst C, Chen D, Zhong H, Chetty IJ. Changes realized from extended bit-depth and metal artifact reduction in CT. Med Phys. 2013;40:061711.

doi: 10.1118/1.4805102 pubmed: 23718590

Ouzaid I, Al-qahtani S, Dominique S, Hupertan V, Fernandez P, Hermieu JF, et al. A 970 Hounsfield units (HU) threshold of kidney stone density on non-contrast computed tomography (NCCT) improves patients’ selection for extracorporeal shockwave lithotripsy (ESWL): evidence from a prospective study. BJU Int. 2012;110:E438–442.

doi: 10.1111/j.1464-410X.2012.10964.x pubmed: 22372937

Nakasato T, Morita J, Ogawa Y. Evaluation of hounsfield units as a predictive factor for the outcome of extracorporeal shock wave lithotripsy and stone composition. Urolithiasis. 2015;43:69–75.

doi: 10.1007/s00240-014-0712-x pubmed: 25139151

Breyer BN, Shindel AW, Huang YC, Eisenberg ML, Weiss DA, Lue TF, et al. Are sonographic characteristics associated with progression to surgery in men with Peyronie’s disease? J Urol. 2010;183:1484–8.

doi: 10.1016/j.juro.2009.12.026 pubmed: 20171694 pmcid: 3565595

Trama F, Illiano E, Iacono F, Ruffo A, di Lauro G, Aveta A, et al. Use of penile shear wave elastosonography for the diagnosis of Peyronie’s Disease: a prospective case-control study. Basic Clin Androl. 2022;15:32.

Yuruk E, Serefoglu EC. Re: Peyronie’s disease plaque calcification–prevalence, time to identification, and development of a new grading classification. J Sex Med. 2014;11:1351.

doi: 10.1111/jsm.12479 pubmed: 24877175

McCullough A, Trussler J, Alnammi M, Schober J, Flacke S. The use of penile computed tomography cavernosogram in the evaluation of Peyronie’s disease: a pilot study. J Sex Med. 2020;17:1041–3.

doi: 10.1016/j.jsxm.2020.01.023 pubmed: 32146129